Grants and Contributions:
Title:
Re-architecture and development of medication decision support platform
Agreement Number:
921602
Agreement Value:
$358,430.00
Agreement Date:
Jan 1, 2019 - Mar 20, 2020
Description:
This project will help the firm redesign the current version of their medication decision support system in order to make it easier to expand and to integrate with other third party software systems. It will also add to the overall functionality of the system by adding 4 new functional modules and enabling it to be used in international markets by supporting geographical differences in language, measurement systems and drug names.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6B 1B6
Reference Number:
172-2018-2019-Q4-921602
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
800398448
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 80 days. The total amended value is 8,430 dollars.
Amendment Date
Dec 18, 2019
Recipient's Legal Name:
GenXys Health Care Systems Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
51121
Amendments: